Literature DB >> 16739114

Jaw1/LRMP, a germinal centre-associated marker for the immunohistological study of B-cell lymphomas.

S Tedoldi1, J C Paterson, J Cordell, S-Y Tan, M Jones, S Manek, A P Dei Tos, H Roberton, N Masir, Y Natkunam, S A Pileri, F Facchetti, M-L Hansmann, D Y Mason, T Marafioti.   

Abstract

Jaw1, also known as lymphoid-restricted membrane protein (LRMP), is an endoplasmic reticulum-associated protein. High levels of Jaw1/LRMP mRNA have been found in germinal centre B-cells and in diffuse large B-cell lymphomas of 'germinal centre' subtype. This paper documents Jaw1/LRMP expression at the protein level in human tissues by immunohistochemical and western blotting analysis using an antibody reactive with paraffin-embedded tissues. Jaw1/LRMP was highly expressed in germinal centre B-cells (in keeping with gene expression data), in 'monocytoid B-cells', and in splenic marginal zone B-cells. It was absent, or present at only low levels, in mature T-cells, although cortical thymocytes were weakly positive. Among lymphoid neoplasms, Jaw1/LRMP was found in germinal centre-derived lymphomas (follicle centre lymphoma, Burkitt's lymphoma, lymphocyte-predominant Hodgkin's disease) but not in T-cell neoplasms (with the exception of a single T lymphoblastic lymphoma). Classical Hodgkin's disease and myeloma lacked Jaw1/LRMP but many cases of chronic lymphocytic leukaemia (but not mantle zone lymphoma) were Jaw1/LRMP-positive. Approximately half of the marginal zone lymphomas were Jaw1/LRMP-positive. In diffuse large B-cell lymphomas, Jaw1/LRMP was found in three-quarters (24/32) of the cases classified phenotypically as being of 'germinal centre' type, but it was also expressed in almost half (13/28) of the 'non-germinal centre' cases. A similar proportion of 'non-germinal centre' cases were positive for the protein products of two other genes expressed highly in germinal centre cells (HGAL/GCET2 and PAG). The fact that all three of these proteins are expressed in a significant proportion of diffuse large B-cell lymphomas assigned to the 'non-germinal centre' category indicates that the immunophenotypic categorization of diffuse large B-cell lymphoma according to cellular origin may be more complicated than currently understood. Finally, the expression of Jaw1/LRMP in other types of lymphoma and in non-lymphoid tissues/tumours may be of interest in differential diagnosis and research. Copyright 2006 Pathological Society of Great Britain and Ireland.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16739114     DOI: 10.1002/path.2002

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  18 in total

1.  Bruton's tyrosine kinase (Btk) is a useful marker for Hodgkin and B cell non-Hodgkin lymphoma.

Authors:  Iván Fernández-Vega; Luis M Quirós; Jorge Santos-Juanes; María Pane-Foix; Teresa Marafioti
Journal:  Virchows Arch       Date:  2014-11-30       Impact factor: 4.064

2.  Subtype-specific addiction of the activated B-cell subset of diffuse large B-cell lymphoma to FOXP1.

Authors:  Joseph D Dekker; Daechan Park; Arthur L Shaffer; Holger Kohlhammer; Wei Deng; Bum-Kyu Lee; Gregory C Ippolito; George Georgiou; Vishwanath R Iyer; Louis M Staudt; Haley O Tucker
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-19       Impact factor: 11.205

3.  The oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas.

Authors:  Yasodha Natkunam; Shuchun Zhao; David Y Mason; Jun Chen; Behnaz Taidi; Margaret Jones; Anne S Hammer; Stephen Hamilton Dutoit; Izidore S Lossos; Ronald Levy
Journal:  Blood       Date:  2006-10-12       Impact factor: 22.113

4.  NOD2 status and human ileal gene expression.

Authors:  Christina M Hamm; Melissa A Reimers; Casey K McCullough; Elizabeth B Gorbe; Jianyun Lu; C Charles Gu; Ellen Li; Brian K Dieckgraefe; Qingqing Gong; Thaddeus S Stappenbeck; Christian D Stone; David W Dietz; Steven R Hunt
Journal:  Inflamm Bowel Dis       Date:  2010-10       Impact factor: 5.325

5.  The pre-B-cell receptor associated protein VpreB3 is a useful diagnostic marker for identifying c-MYC translocated lymphomas.

Authors:  Scott J Rodig; Jeffery L Kutok; Jennifer C Paterson; Hiroaki Nitta; Wenjun Zhang; Bjoern Chapuy; Lynette K Tumwine; Santiago Montes-Moreno; Claudio Agostinelli; Nathalie A Johnson; Susana Ben-Neriah; Pedro Farinha; Margaret A Shipp; Miguel A Piris; Thomas M Grogan; Stefano A Pileri; Randy D Gascoyne; Teresa Marafioti
Journal:  Haematologica       Date:  2010-09-07       Impact factor: 9.941

6.  Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease.

Authors:  Stephanie Bertram; Ilona Glowacka; Marcel A Müller; Hayley Lavender; Kerstin Gnirss; Inga Nehlmeier; Daniela Niemeyer; Yuxian He; Graham Simmons; Christian Drosten; Elizabeth J Soilleux; Olaf Jahn; Imke Steffen; Stefan Pöhlmann
Journal:  J Virol       Date:  2011-10-12       Impact factor: 5.103

7.  Detection of genetic alterations by immunoFISH analysis of whole cells extracted from routine biopsy material.

Authors:  Göran Mattsson; Soo Yong Tan; David J P Ferguson; Wendy Erber; Susan H Turner; Teresa Marafioti; David Y Mason
Journal:  J Mol Diagn       Date:  2007-08-09       Impact factor: 5.568

8.  Optimization based tumor classification from microarray gene expression data.

Authors:  Onur Dagliyan; Fadime Uney-Yuksektepe; I Halil Kavakli; Metin Turkay
Journal:  PLoS One       Date:  2011-02-04       Impact factor: 3.240

9.  Gene selection and cancer type classification of diffuse large-B-cell lymphoma using a bivariate mixture model for two-species data.

Authors:  Yuhua Su; Dahlia Nielsen; Lei Zhu; Kristy Richards; Steven Suter; Matthew Breen; Alison Motsinger-Reif; Jason Osborne
Journal:  Hum Genomics       Date:  2013-01-05       Impact factor: 4.639

10.  Sequence based analysis of U-2973, a cell line established from a double-hit B-cell lymphoma with concurrent MYC and BCL2 rearrangements.

Authors:  Sean D Hooper; Xiang Jiao; Elisabeth Sundström; Farah L Rehman; Christian Tellgren-Roth; Tobias Sjöblom; Lucia Cavelier
Journal:  BMC Res Notes       Date:  2012-11-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.